U.S. pharma huge copyright scrapped two experimental weight loss capsules final yr—a the moment-each day tablet, lotiglipron, due to elevated liver enzymes as well as a two times-day-to-day tablet, danuglipron, due to strong side effects—but CEO Albert Bourla has said the company is determined to “Participate in and gain” within the being o